Previous 10 | Next 10 |
Tobacco company 22nd Century Group (NYSEMKT: XXII) has been one of the hottest stocks to buy this year. Its shares have already climbed more than 120%, dwarfing the S&P 500 and its 13% gains. There is an awful lot of bullishness behind a business that has generated losses th...
BUFFALO, N.Y., June 25, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today released an update letter to its shareholders from...
BUFFALO, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it closed the previously announced ...
FN Media Presents Rotten Tomato Stocks Commentary Vancouver, BC – June 9, 2021 – Rotten Tomato Stocks – As we move into June to close out the standard fiscal quarter for Q2 2021, it’s worth looking back at some of the cannabis sector...
BUFFALO, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, is pleased to announce that it will be added to the Russ...
Marijuana stocks are growing again Monday -- with a little help from 22nd Century Group (NYSEMKT: XXII) . In a pair of press releases, 22nd Century first announced that it is selling 10 million shares of stock to an institutional investor at $4 a share, in order to raise $40...
Close Partnership With Aurora Cannabis Inc. to Enforce Shared Global Biosynthesis IP Rights Against Infringement and Actively Explore Commercial Development Opportunities; Monetization of Key Patented Technology Expected in Second Half of 2021 Secures Strategic Partnerships ...
BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it has entered into a definitive ag...
Currently trading at $4.50, plant-based biotech company 22nd Century Group (XXII) has garnered significant investor attention to its VLN cigarette based on the expectation that the FDA will soon release a proposal for the reduction of nicotine levels in cigarettes. However, given that the com...
BUFFALO, N.Y., May 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the ...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...